What Connecticut Medicaid actually covers for Wegovy, Zepbound, Ozempic and Mounjaro. Most state Medicaid programs still exclude weight-loss-indication GLP-1, but the diabetes path is covered nearly everywhere with prior authorization (your doctor asks the plan to approve it first). Here is the current 2026 reality for Connecticut.
Coverage summary
| Indication | Coverage |
|---|---|
| Wegovy (weight loss) | No |
| Zepbound (weight loss) | Limited |
| Ozempic / Mounjaro (type 2 diabetes) | Yes |
| Compounded semaglutide / tirzepatide | No |
Prior-authorization criteria
These rules come from the state preferred drug list (PDL), the list of drugs Connecticut Medicaid has agreed to pay for.
| Criterion | Value |
|---|---|
| PA burden | Medium |
| BMI threshold (weight-loss path) | The state does not publish one. Ask your plan. |
| Comorbidity required | No |
| Last PDL update reviewed | 2024-Q4 |
What this means in practice
Connecticut Medicaid (HUSKY Health) does not cover GLP-1s for weight loss on its own. It does cover them for four other reasons. Wegovy is covered to cut heart attack and stroke risk, and for MASH, a fatty liver disease. Zepbound is covered for moderate to severe sleep apnea, which means your sleep study scored 15 or higher and you are already on a CPAP machine. That one has been in place since July 1, 2025. Type 2 diabetes is the fourth route. All four need your doctor to get approval first. That is the prior authorization step.
Managed-care organizations in Connecticut
Connecticut Medicaid operates primarily as fee-for-service. PA submissions go directly to the state Medicaid pharmacy benefit administrator rather than to a contracted managed-care organization (MCO), the kind of private health plan that runs Medicaid coverage in most states.
Cash-pay alternatives if Medicaid does not cover you
Connecticut's Medicaid weight-loss drug benefit covers orlistat, Xenical and phentermine at a BMI above 40, or above 35 with a diagnosed comorbid condition. No GLP-1 is on that list. Type 2 diabetes on your chart still opens the diabetes route.
If you end up paying cash, the GLP-1 cost guide breaks down what every legitimate path actually costs at maintenance dose, from the $149-a-month compounded floor to branded manufacturer-direct pricing. For ranked cash-pay options, see programs ranked by price and programs under $150 a month. Manufacturer savings cards and patient-assistance programs are not routes here: federal law bars the cards for anyone on Medicaid, and the free-drug programs require being uninsured.
Two routes sit outside Medicaid entirely. If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.
For the full cash-pay picture specific to Connecticut, including which programs serve Connecticut residents and the Connecticut Medicaid cost comparison, see the cheapest GLP-1 in Connecticut guide.
Take it to your prescriber: PA letter library
If you qualify under one of the covered indications above, the prior-authorization route is the cheapest path. We maintain a PA letter library with templates for Aetna, Cigna, UnitedHealthcare, Anthem BCBS, Kaiser, Humana, Tricare, FEHB and Medicare Advantage, cross-indexed against six qualifying clinical pictures. Each template cites the plan's policy document, the qualifying ICD-10 codes and the registration-trial evidence.
If you have type 2 diabetes plus chronic kidney disease and established cardiovascular disease, the triple-indication evidence stack (FLOW + SELECT + SUSTAIN-6) is the strongest PA path in any state.
If your PA is denied, the appeal letter library has denial-specific templates. For the commercial and Medicare coverage paths, see the GLP-1 insurance guide.
Connecticut Medicaid GLP-1 FAQ
Does HUSKY Health (Connecticut Medicaid) cover Wegovy for weight loss?
Does HUSKY Health (Connecticut Medicaid) cover Zepbound for weight loss?
Does HUSKY Health (Connecticut Medicaid) cover Ozempic or Mounjaro for diabetes?
What if HUSKY Health (Connecticut Medicaid) does not cover my GLP-1?
Other state Medicaid pages
See the full 51-state coverage table for the side-by-side view across every US state.
How we built this page
Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.
Last updated: 2026-07-20. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Connecticut Medicaid, email hello@glpchart.com with the details and we will check it.
